FDA
approval
· 2023-04-19
FDA Approved: LAMIVUDINE AND ZIDOVUDINE — Supplemental Application (Camber Pharmaceuticals, Inc.)
Summary
FDA approved Camber Pharmaceuticals' supplemental application for a generic lamivudine and zidovudine tablet product, a fixed-dose combination antiretroviral us…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for LAMIVUDINE AND ZIDOVUDINE (LAMIVUDINE AND ZIDOVUDINE)